Cite
COX-2, TFF1, and Src define better prognosis in young patients with gastric cancer
MLA
Claus, Schildberg, et al. “COX-2, TFF1, and Src Define Better Prognosis in Young Patients with Gastric Cancer.” Journal of Surgical Oncology, vol. 108, no. 6, May 2013. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........d7af1dd0e446b132631e6ed320e46e6b&authtype=sso&custid=ns315887.
APA
Claus, S., M, A., S, M., A, A., A, D., A, S., R, C., J, L., W, H., & H, A. (2013). COX-2, TFF1, and Src define better prognosis in young patients with gastric cancer. Journal of Surgical Oncology, 108(6).
Chicago
Claus, Schildberg, Abbas M, Merkel S, Agaimy A, Dimmler A, Schlabrakowski A, Croner R, Leupolt J, Hohenberger W, and Allgayer H. 2013. “COX-2, TFF1, and Src Define Better Prognosis in Young Patients with Gastric Cancer.” Journal of Surgical Oncology 108 (6). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........d7af1dd0e446b132631e6ed320e46e6b&authtype=sso&custid=ns315887.